Results 181 to 190 of about 14,143,268 (384)

Synthesis of single-site copper catalysts for methane partial oxidation

, 2015
Sebastian Grundner, Wenhao Luo, Maricruz Sanchez‐Sanchez, Johannes A. Lercher   +3 more
openalex   +2 more sources

Suitability Evaluation of Popular Science Tourism Sites in University Towns: Case Study of Guangzhou University Town [PDF]

, 2022
Guo Wei, Dafang Wu, Yue Li, Feng-Xi Wang, Yong-Qi Ye, Huawei Lin, Chi-Fang Zhang   +6 more
openalex   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

An Atom Probe Tomography study of site preference and partitioning in a nickel-based superalloy

, 2016
Paul A.J. Bagot, O.B.W. Silk, James O. Douglas, S. Pedrazzini, D.J. Crudden, T. Martin, Mark Hardy, Michael P. Moody, R.C. Reed   +8 more
openalex   +2 more sources

Development of a standard database of reference sites for validating global burned area products [PDF]

, 2020
Magí Franquesa, Melanie K. Vanderhoof, Dimitris Stavrakoudis, Ioannis Z. Gitas, Ekhi Roteta, Marc Padilla, Emilio Chuvieco   +6 more
openalex   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Pd ^II –Catalyzed Site-selective β- and γ-C(sp ³ )–H Arylation of Primary Aldehydes Controlled by Transient Directing Groups

, 2022
Yi-Hao Li, Yuxin Ouyang, Nikita Chekshin, Jin‐Quan Yu   +3 more
openalex   +2 more sources

Liquid biopsy epigenetics: establishing a molecular profile based on cell‐free DNA

Molecular Oncology, EarlyView.
Cell‐free DNA (cfDNA) fragments in plasma from cancer patients carry epigenetic signatures reflecting their cells of origin. These epigenetic features include DNA methylation, nucleosome modifications, and variations in fragmentation. This review describes the biological properties of each feature and explores optimal strategies for harnessing cfDNA ...
Christoffer Trier Maansson, Anders Lade Nielsen, Boe Sandahl Sorensen   +2 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

Molecular Oncology, EarlyView.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz, Anna L. Bartkowiak, Michael Rose, Nora Kolks, Patrick Petzsch, Vandana Solanki, Anne Stoffel, Bianca Faßbender, Leandra Lepping, Julka Volkamer, Karl Köhrer, Marc Seifert, Tokameh Mahmoudi, Tahlita C. M. Zuiverloon, Günter Niegisch, Michèle J. Hoffmann   +15 more
wiley   +1 more source

Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Proceedings of the National Academy of Sciences of the United States of America, 2004
G. Calin, C. Sevignani, C. Dumitru, T. Hyslop, E. Noch, S. Yendamuri, M. Shimizu, Sashi Rattan, F. Bullrich, M. Negrini, C. Croce   +10 more
semanticscholar   +1 more source